Catrinia Druen
Family Medicine · Horse Cave, KYNPI 1497161764
Payments from drug & device makers
Across 375 payments — averaging $16.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- GSK$702
- Axsome Therapeutics, Inc.$647
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$503
- Lilly USA, LLC$421
- AstraZeneca$414
- plus $2K from 29 others
What the payments were for
- Food & beverage$6,058100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 98 | $1,428 |
| GSK | 53 | $702 |
| Axsome Therapeutics, Inc. | 31 | $647 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 26 | $503 |
| Lilly USA, LLC | 27 | $421 |
| AstraZeneca | 21 | $414 |
| Pfizer | 27 | $397 |
| Amgen | 19 | $331 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $187 |
| Otsuka America Pharmaceutical, Inc. | 9 | $158 |
| Novo Nordisk | 8 | $126 |
| Corium, LLC | 6 | $98 |
| Amarin Pharma, Inc. | 5 | $74 |
| Alkermes, Inc. | 3 | $63 |
| Merck | 3 | $63 |
| Lundbeck LLC | 2 | $41 |
| Biohaven Pharmaceuticals, Inc. | 2 | $39 |
| Exact Sciences | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Indivior Inc. | 1 | $28 |
| Johnson & Johnson | 2 | $24 |
| Harmony Biosciences LLC | 1 | $19 |
| USWM, LLC | 1 | $19 |
| Corcept Therapeutics | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $18 |
| Radius Health, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
| Shield Therapeutics Inc | 1 | $15 |
| Medtronic | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Athena Bioscience, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,058 in reported general payments places this provider in the 85th percentile of 1,559 family medicine providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 107 | $114,779 |
| VraylarCariprazine Hcl | 56 | $78,816 |
| OzempicSemaglutide | 67 | $62,404 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 82 | $51,184 |
| EliquisApixaban | 48 | $33,185 |
| FarxigaDapagliflozin Propanediol | 38 | $31,883 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 60 | $28,540 |
| LinzessLinaclotide | 47 | $25,613 |
| CaplytaLumateperone Tosylate | 14 | $22,795 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 136 | $20,801 |
| XareltoRivaroxaban | 27 | $16,966 |
| JardianceEmpagliflozin | 20 | $16,507 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $14,320 |
| Tresiba Flextouch U-200Insulin Degludec | 16 | $13,099 |
| Repatha SureclickEvolocumab | 15 | $8,798 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $421 | $114,779107 claims |
| AbbVieVraylar, Linzess | $1,428 | $104,429103 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta | $702 | $70,385130 claims |
| Novo NordiskOzempic | $126 | $62,40467 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Brilinta, Symbicort | $414 | $55,39988 claims |
| PfizerEliquis | $397 | $33,18548 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $18 | $22,87533 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $503 | $22,79514 claims |
| Johnson & JohnsonXarelto | $24 | $16,96627 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $187 | $7,21417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Horse Cave
- Brian SmithVersailles$7.7M
- Barbara Fleming-PhillipsLexington$1.4M
- Christopher RhyneLouisville$1M
- Kruti PatelBurlington$463K
- Michael LovelaceLouisville$244K
- John RichardLexington$226K
- Diego MastronardiBowling Green$196K
- James TurnboPaducah$124K
- Eleida Tur OlivaLexington$113K
- Jeffrey GreenParis$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.